reports
Alleima AB: 1 director
A director at Alleima AB bought 900,000 shares at 69.824SEK and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly s...
Swedbank AB: 2 directors
A director at Swedbank AB bought 2,350 shares at 211.100SEK and the significance rating of the trade was 47/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly s...
GFH Financial Group B.S.C: 1 director
A director at GFH Financial Group B.S.C bought 1,202,117 shares at 0.295USD and the significance rating of the trade was 83/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two...
Redx Pharma: 2 directors
Two Directors at Redx Pharma bought/maiden bought 267,108 shares at between 10p and 12p. The significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the...
Mr D.I.Y. Group (M) Berhad: 1 director
A director at Mr D.I.Y. Group (M) Berhad sold 140,000 shares at 1.570MYR and the significance rating of the trade was 53/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ye...
Edison issues update on The Merchants Trust (MRCH): Celebrating its 13...
Edison Investment Research Limited Edison issues update on The Merchants Trust (MRCH): Celebrating its 135th anniversary 30-Apr-2024 / 10:03 GMT/BST The issuer is solely responsible for the content of this announcement. London, UK, 30 April 2024 Edison issues update on The Merchants Trust (MRCH): Celebrating its 135th anniversary The Merchants Trust’s (MRCH’s) manager, Simon Gergel at Allianz Global investors, is very excited about the number of reasonably priced opportunities available in the UK market. Also, good income generation from the trust’s portfolio of high-qual...
- Aurelien Sivignon
Bigben Interactive : Unsurprising Q4
>As usual, Nacon lifted growth, even though Audio/Telco did slightly better - Bigben Interactive published yesterday evening Q4 (January-March) revenues up 7% YoY to € 69.7m, in line with our expectations (€ 68.9m est.). FY revenues were up 3% YoY to € 291.9m. In detail: Audio/Telco (41% of Q4 revenues) came in slightly up by 2% at € 28.8m (€ 26.2m est.), driven by a resilient Mobile Accessories business (81% of the division's revenues), up 8% to € 23.3m, desp...
EQS-News: MERKUR PRIVATBANK bleibt im ersten Quartal 2024 auf Wachstum...
EQS-News: MERKUR PRIVATBANK KGaA / Schlagwort(e): Quartals-/Zwischenmitteilung MERKUR PRIVATBANK bleibt im ersten Quartal 2024 auf Wachstumskurs 30.04.2024 / 11:00 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. PRESSEMITTEILUNG MERKUR PRIVATBANK bleibt im ersten Quartal 2024 auf Wachstumskurs Auch in einem dynamischen Marktumfeld konnten die Erträge erneut gesteigert werden. Maßgeblich dafür sind ein diversifiziertes Geschäftsmodell und die solide Finanzierungsstruktur. München, 30. April 2024 – Die MERKUR PRIVATBANK KGaA se...
- Geoffroy Michalet
Antin Infrastructure Partners : Un T1 calme sur le front de la collect...
>Collecte faible pour ce T1, le groupe continue d’afficher sa confiance pour 2024 - Le groupe publie ce matin ses AUM (sans CA ni profitabilité, comme de coutume lors des trimestres intermédiaires).Le fait saillant de cette publication est la faible collecte du seul fonds en cours de levée, le fonds Flagship V. Elle se monte à 0.1 Md€ au titre du premier trimestre, portant les engagements de souscriptions du fonds V à 9.1 Md€ (vs 9.0 Md€ fin 2023). Ce niveau est ...
Fortuna renews share repurchase program
Fortuna renews share repurchase program VANCOUVER, British Columbia, April 30, 2024 (GLOBE NEWSWIRE) -- Fortuna Silver Mines Inc. (TSX: FVI) (NYSE: FSM) announced today that the Toronto Stock Exchange has approved the renewal of Fortuna’s normal course issuer bid (the “NCIB”) to purchase up to five percent of its outstanding common shares. Under the NCIB, purchases of common shares may be made through the Toronto Stock Exchange, the New York Stock Exchange and/or alternative Canadian trading systems. The share repurchase program starts on May 2, 2024 and will expire on the earlier of: ...
Xtant Medical Announces Launch of SimpliGraft™ and SimpliMax™ for Chro...
Xtant Medical Announces Launch of SimpliGraft™ and SimpliMax™ for Chronic and Acute Wounds BELGRADE, Mont., April 30, 2024 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the full commercial launch of two amniotic membrane allografts, SimpliGraft™ and SimpliMax™. “The launches of SimpliGraft and SimpliMax highlights the strength of our newly revitalized Research and Development team,” said Sean Browne, President and CEO of Xtant Medical. “...
Neusoft Reach and Ambarella Forge Strategic Partnership to Drive Advan...
Neusoft Reach and Ambarella Forge Strategic Partnership to Drive Advancements in Autonomous Driving and Intelligent Automotive Technology SHANGHAI, China and SANTA CLARA, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- Automotive Technology (Shanghai) Co., Ltd., a subsidiary of Neusoft specializing in intelligent vehicle technology, and , Inc. (NASDAQ: AMBA), an edge AI semiconductor company, announced the establishment of a strategic partnership at the Beijing Auto Show. This cooperation is based on the strong resources and advantages of both parties in areas such as automotive software, aut...
- Ignacio Romero
- Jean Danjou
- Oliver Metzger
Fielmann AG : Top-line trends rather supportive but the guidance on pr...
>FY 2023 results confirmed, Q1 sales growth quite supportive at +11% but Q1 EBT just in line, FY 2024 growth expected double digit with EBT margin to improve - As usual at this point in the year, Fielmann releases at the same time 1) the final and complete FY 2023 results (prelim figures are reconfirmed: revenues at € 1970m, EBITDA at € 410m a 20.8% margin, EBT at € 194m 9.8% margin), 2) the results for Q1 2024: sales at € 529m, up 11% EBITDA at € 117m (margin 22.1% f...
- Ahmed Ben Salem
GALP : Q1 2024 results: strong beat to consensus with robust cashflow
>Q1 2024: 12% beat on EBITDA, 23% for EBIT and 28% for NI - GALP has just released its Q1 2024 results with EBITDA of € 974m, 12% above the consensus and 14% above our estimates. EBIT came in at € 776m (up 88.8% q-o-q), 23.4% above the consensus. Adjusted net income was € 337m (+18.7% q-o-q) and 28.6% above the consensus. Robust results supported by refining - Upstream: adjusted EBITDA was € 591m (vs € 599m in Q4), 9% above the consensus with lower ...
Moody's Ratings affirms Airbus A2 rating; changes outlook to positive ...
Moody's Ratings (Moody's) has today affirmed Airbus SE's (Airbus) senior unsecured and short term issuer ratings at A2 and P-1 respectively. Concurrently, Moody's has affirmed Airbus SE's senior unsecured MTN program rating at (P)A2, its Commercial Paper rating at P-1, the backed senior unsecured ra...
- Jin Yoon
GOTO 1Q24 Results: Reinvest Profit to Drive Growth
What’s New: GoTo reiterated its adjusted EBITDA breakeven guidance as the group could potentially reinvest any profit back to the business to drive growth in FY24. ODS and FinTech growth could also remain resilient as GoTo plans to double down investments on the successful initiatives within each segment. We maintain our PT at IDR65. Analysts: Jin Yoon
AB “Grigeo” transferred the tissue paper business to its subsidiary
AB “Grigeo” transferred the tissue paper business to its subsidiary AB “Grigeo” (the official name is currently being changed to AB “Grigeo Group”, hereinafter – the Company) has implemented structural changes of Grigeo group of companies. On 30 April 2024 the Company has transferred the tissue paper business to 100% owned subsidiary UAB “Grigeo Tissue”, legal entity code 306639125, address Vilniaus g. 10, Grigiškės, Vilnius City Municipality, the Republic of Lithuania, data about the company is collected and stored with the Register of Legal Entities of the Republic of Lithuania (hereina...
AB „Grigeo“ perleido higieninio popieriaus verslą dukterinei bendrovei
AB „Grigeo“ perleido higieninio popieriaus verslą dukterinei bendrovei AB „Grigeo“ (šiuo metu oficialus pavadinimas keičiamas į AB „Grigeo Group“, toliau – Bendrovė) įgyvendino Grigeo įmonių grupės struktūros pokyčius. 2024 m. balandžio 30 d. Bendrovė perleido higieninio popieriaus verslą 100 proc. valdomai dukterinei bendrovei UAB „Grigeo Tissue“, juridinio asmens kodas 306639125, adresas Vilniaus g. 10, Grigiškės, Vilniaus m. sav., Lietuvos Respublika, duomenys apie bendrovę kaupiami ir saugomi Lietuvos Respublikos juridinių asmenų registre (toliau – Grigeo Tissue). Higieninio popie...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.